AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Intelligent Bio Solutions Inc. Common Stock
XNAS · usd
SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
FIGI BBG004TP0VY8
1.59▼ 0.09 (-5.64%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
—
Trailing P/E
—
Price / Sales
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
—
Trading Information
Previous Close
1.69
Day's Range
1.58 – 1.66
52-Week Range
0.54 – 24.91
Volume
20.7K
Avg Volume
38.5K
Share Statistics
Shares Outstanding
Employees
55
Exchange
XNAS
Listed
2020-12-23
Share count as of August 18, 2026

Intelligent Bio Solutions Inc. Common Stock (INBS) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Intelligent Bio Solutions Inc. Common Stock (INBS)
What is Intelligent Bio Solutions Inc. Common Stock's Market Cap?
Intelligent Bio Solutions Inc. Common Stock's Market Cap is $4.8M, based on as-reported figures from SEC (XBRL) filings.
What is Intelligent Bio Solutions Inc. Common Stock's Price / Sales?
Intelligent Bio Solutions Inc. Common Stock's Price / Sales is 1.1×, based on as-reported figures from SEC (XBRL) filings.
What is Intelligent Bio Solutions Inc. Common Stock's Revenue (TTM)?
Intelligent Bio Solutions Inc. Common Stock's Revenue (TTM) is $4.2M, based on as-reported figures from SEC (XBRL) filings.
What is Intelligent Bio Solutions Inc. Common Stock's Net Income (TTM)?
Intelligent Bio Solutions Inc. Common Stock's Net Income (TTM) is -$12.4M, based on as-reported figures from SEC (XBRL) filings.
What is Intelligent Bio Solutions Inc. Common Stock's EBITDA?
Intelligent Bio Solutions Inc. Common Stock's EBITDA is -$11.4M, based on as-reported figures from SEC (XBRL) filings.
What is Intelligent Bio Solutions Inc. Common Stock's Diluted EPS (TTM)?
Intelligent Bio Solutions Inc. Common Stock's Diluted EPS (TTM) is -4.11, based on as-reported figures from SEC (XBRL) filings.
What is Intelligent Bio Solutions Inc. Common Stock's EBITDA Margin?
Intelligent Bio Solutions Inc. Common Stock's EBITDA Margin is -271.5%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · INBSAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemDec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022
Revenue
YoY growth+47.6%+27.5%+15.9%-11.5%
Cost of revenue (exclusive of amortization shown separately below)
Gross profit
% of revenue51.3%46.6%39.8%46.8%
Other income
Government support income
Operating expenses
Selling, general and administrative expenses
Development and regulatory approval expenses
Depreciation and amortization
Impairment of long-lived assets——
Total operating expenses
% of revenue-353.3%-333.8%-456.9%-420.9%
Loss from operations
% of revenue-293.9%-269.8%-371.6%-350.3%
Other income (expense), net
Interest expense
Non-Operating Income (Expense)——
Interest and Dividend Income (Non-Bank)
Total other income, net
Net loss
% of revenue-299.6%-269.4%-367.7%-350.0%
Net Income Attributable to Noncontrolling Interest
Net loss attributable to Intelligent Bio Solutions Inc.
% of revenue-298.6%-268.3%-366.2%-349.0%
Net Income Attributable to Noncontrolling Interest
Comprehensive loss attributable to Intelligent Bio Solutions Inc.
Earnings Per Share (Basic)—
Earnings Per Share (Diluted)—